home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Harnessing The Activity Of A Detox Enzyme

  April, 27 2004 9:25
your information resource in human molecular genetics
Researchers have determined the structure of an enzyme that inactivates the nerve agent sarin and related toxic molecules. The results, published in the May issue of Nature Structural & Molecular Biology, provide insights into how the enzyme selects its targets and how this selectivity can be fine-tuned toward a particular set of targets.

Paraoxonase cleaves and inactivates toxic organophosphates such as sarin. It is also a component of the high-density lipoprotein particle (HDL, the 'good cholesterol') and its activity is involved in preventing the formation of fatty deposits on the artery walls. Paraoxonase is thus valuable from both antibioterrorism and medical perspectives. To understand how a single enzyme can act on such a broad spectrum of targets, Danny Tawfik and colleagues have determined the crystal structure of a mammalian paraoxonase. Structural and mutational analyses suggest the location of the active site and how the enzyme selects its targets. These results provide a basis for engineering the enzyme's activity toward a subset of its substrates for various biomedical applications.

Author contact:

Dan S. Tawfik
The Weizmann Institute of Science
Rehovot, Israel
Tel: +972 8 934 3637
E-mail: tawfik@weizmann.ac.il

Also available online.

(C) Nature Structural & Molecular Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.